IBOV 172,236.05 ▲ 2.22% IPC MEX 71,866.30 ▲ 0.66% MERVAL 2,848,945 — — USD/BRL5.58▲ 1.23% USD/MXN18.71▲ 0.95% USD/CLP976.53▲ 0.96% USD/COP3,292▲ 5.51% USD/PEN3.41▲ 0.02% USD/ARS1,545▼ 0.02% USD/UYU40.45▲ 0.35% USD/PYG6,450▲ 1.45% USD/BOB11.74▼ 0.59% USD/DOP60.45▲ 2.39% USD/CRC446.56▼ 0.38% USD/GTQ7.64▼ 0.05% USD/HNL26.89▲ 0.02% USD/NIO36.62▲ 2.53% USD/VES897.02▲ 0.07% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 2.42% USD/TTD6.72▼ 0.03% EUR/BRL6.24▲ 1.72% BRENT 89.56 ▼ 3.25% WTI 84.49 ▼ 2.72% IRON ORE 161.91 — — COPPER 6.25 ▼ 1.17% GOLD 4,058 ▼ 1.37% SILVER 51.77 ▼ 1.51% SOY 1,186 ▲ 0.34% CORN 439.75 ▲ 0.11% WHEAT 586.00 ▼ 0.34% COFFEE 265.40 ▼ 3.00% SUGAR 18.02 ▼ 1.04% ORANGE JUICE 144.80 ▲ 4.66% COTTON 78.30 ▼ 0.61% COCOA 4,860 ▼ 2.88% BEEF 216.33 ▲ 1.06% CATTLE 328.83 ▲ 2.02% LITHIUM 61.35 ▲ 0.72% PETR4 44.68 ▼ 1.13% VALE3 65.20 ▼ 1.38% ITUB4 41.82 ▲ 0.24% BBDC4 14.65 ▼ 0.20% ABEV3 15.63 ▲ 0.13% BBAS3 17.09 ▲ 0.41% B3SA3 14.90 ▲ 0.34% WEGE3 51.64 ▲ 1.77% PRIO3 59.02 ▼ 0.62% SUZB3 54.72 ▲ 0.96% RENT3 30.43 ▼ 1.30% AZZA3 15.04 ▼ 0.53% CSAN3 2.74 ▼ 1.08% RAIZ4 24.40 ▼ 12.86% PCAR3 2.40 ▼ 1.23% GMAT3 3.87 ▲ 1.04% PSSA3 45.81 ▲ 0.35% CVCB3 0.86 ▼ 1.15% POSI3 3.06 ▲ 0.99% SLCE3 16.95 ▼ 2.02% NATU3 5.63 ▼ 1.40% BRKM5 3.03 ▲ 0.33% RANI3 8.46 ▼ 3.42% CSNA3 4.43 ▼ 1.34% IBOV 172,236.05 ▲ 2.22% IPC MEX 71,866.30 ▲ 0.66% MERVAL 2,848,945 — — USD/BRL 5.58 ▲ 1.23% USD/MXN 18.69 ▲ 0.87% USD/CLP 976.65 ▲ 0.97% USD/COP 3,288 ▲ 5.40% USD/PEN 3.41 ▲ 0.02% USD/ARS 1,545 ▼ 0.02% USD/UYU 40.45 ▲ 0.35% USD/PYG 6,450 ▲ 1.45% USD/BOB 11.74 ▼ 0.59% USD/DOP 60.45 ▲ 2.39% USD/CRC 446.56 ▼ 0.38% USD/GTQ 7.64 ▼ 0.05% USD/HNL 26.89 ▲ 0.02% USD/NIO 36.62 ▲ 2.53% USD/VES 897.02 ▲ 0.07% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 2.42% USD/TTD 6.72 ▲ 2.10% EUR/BRL 6.24 ▲ 1.72% BRENT 89.56 ▼ 3.25% WTI 84.49 ▼ 2.72% IRON ORE 161.91 — — COPPER 6.25 ▼ 1.17% GOLD 4,058 ▼ 1.37% SILVER 51.77 ▼ 1.51% SOY 1,186 ▲ 0.34% CORN 439.75 ▲ 0.11% WHEAT 586.00 ▼ 0.34% COFFEE 265.40 ▼ 3.00% SUGAR 18.02 ▼ 1.04% ORANGE JUICE 144.80 ▲ 4.66% COTTON 78.30 ▼ 0.61% COCOA 4,860 ▼ 2.88% BEEF 216.33 ▲ 1.06% CATTLE 328.83 ▲ 2.02% LITHIUM 61.35 ▲ 0.72% PETR4 44.68 ▼ 1.13% VALE3 65.20 ▼ 1.38% ITUB4 41.82 ▲ 0.24% BBDC4 14.65 ▼ 0.20% ABEV3 15.63 ▲ 0.13% BBAS3 17.09 ▲ 0.41% B3SA3 14.90 ▲ 0.34% WEGE3 51.64 ▲ 1.77% PRIO3 59.02 ▼ 0.62% SUZB3 54.72 ▲ 0.96% RENT3 30.43 ▼ 1.30% AZZA3 15.04 ▼ 0.53% CSAN3 2.74 ▼ 1.08% RAIZ4 24.40 ▼ 12.86% PCAR3 2.40 ▼ 1.23% GMAT3 3.87 ▲ 1.04% PSSA3 45.81 ▲ 0.35% CVCB3 0.86 ▼ 1.15% POSI3 3.06 ▲ 0.99% SLCE3 16.95 ▼ 2.02% NATU3 5.63 ▼ 1.40% BRKM5 3.03 ▲ 0.33% RANI3 8.46 ▼ 3.42% CSNA3 4.43 ▼ 1.34%
since 2009
Tuesday, November 10, 2026

Covid-19 Brazil

Brazil to spend extra US$1 billion to fight pandemic as country hits daily death record

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Brazil’s President Jair Bolsonaro on Tuesday, March 30, signed an executive order to disburse R$5.3 billion (US$918.08 million) in new loans to fight the Covid-19 pandemic, as the country hit a record tally of 3,780 deaths in the past day.

Brazil currently accounts for about a quarter of Covid-19 daily deaths worldwide, more than any other country, and a lack of shots has hampered its vaccination efforts.

Brazil to spend extra US$1 billion to fight pandemic as country hits daily death record
Brazil to spend extra US$1 billion to fight pandemic as country hits daily death record.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Bolsonaro has been widely condemned for his handling of the pandemic, from playing down the disease’s severity to criticizing early efforts to secure vaccines and opposing social distancing measures.

The new loans will be used to prop up Brazil’s health system, the finance ministry said. The health ministry will receive the funding and said it would use it at over 2,600 public health clinics and build more hospital beds.

On Tuesday, older Brazilians in Rio de Janeiro state waited in long lines under the strong sun to get vaccinated. While Brazil hoped to have 46 million doses of the vaccine in March, it received only 22 million.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon takes a first step back to Venezuela”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

“After all this sacrifice, in this sun, we will see if we can get (the vaccine), but it looks unlikely, it is very disorganized,” said Ira Salazar, a retiree who was at the back of a line with more than 100 people.

On Tuesday, Brazil’s health regulatory agency Anvisa said the Covaxin COVID-19 vaccine, developed by India’s Bharat Biotech, did not meet its manufacturing standards.

The Brazilian government signed a contract last month to buy 20 million doses of Covaxin. Bharat Biotech had applied for emergency use of the vaccine in Brazil on March 8.

Bharat and its Brazilian partner Precisa Medicamentos said in a statement that they would appeal the decision and would present evidence that it is complying with all requirements.

Covaxin has been approved for use in five countries, including India, the statement said.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.